Jan Mattsson - Oct 24, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Scientific Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Oct 24, 2022
Transactions value $
-$3,954
Form type
4
Date filed
10/25/2022, 04:00 PM
Previous filing
Jul 25, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$3.95K -202 -0.35% $19.58 57.8K Oct 24, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 33,065 shares of common stock and 24,694 restricted stock units.